Canadian pipeline operator Enbridge exceeded market estimates for first-quarter profit on Friday, driven in part by higher ...

SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

Royalty Receipts was $788 million in the first quarter of 2025, an increase of 12% compared to $705 million in the first quarter of 2024. The increase was primarily driven by strong growth from the ...

Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...

SaaS revenue grows 16% (constant currency1 17%), adjusted EBITDA1 margin of 25% Annual recurring revenue2 grows 14% (constant currency1 14%) FY 2025 guidance reiterated after solid first quarter ...

Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAGR of 7.5%. BURLINGAME, CA, UNI ...

Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.

Shares of First Solar Inc. dropped about 11% in the extended session Tuesday after the solar-panel maker reported quarterly profit that ... Solar FSLR cut its 2025 outlook for sales to between ...

Pfizer expanded its cost-cutting plans and posted first-quarter profit above estimates, despite a decline in sales driven by ...

Pfizer's finance chief, Dave Denton, said in the same call that the tariffs currently in place are expected to cost the company about $150 million in 2025. Pharmaceutical products were exempted ...